Details for New Drug Application (NDA): 211844
✉ Email this page to a colleague
NDA 211844 describes MIDAZOLAM IN 0.9% SODIUM CHLORIDE, which is a drug marketed by Gland, Hikma, and Inforlife, and is included in three NDAs. It is available from five suppliers. There is one patent protecting this drug. Additional details are available on the MIDAZOLAM IN 0.9% SODIUM CHLORIDE profile page.
The generic ingredient in MIDAZOLAM IN 0.9% SODIUM CHLORIDE is midazolam. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the midazolam profile page.
The generic ingredient in MIDAZOLAM IN 0.9% SODIUM CHLORIDE is midazolam. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the midazolam profile page.
Summary for 211844
| Tradename: | MIDAZOLAM IN 0.9% SODIUM CHLORIDE |
| Applicant: | Inforlife |
| Ingredient: | midazolam |
| Patents: | 1 |
Suppliers and Packaging for NDA: 211844
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | midazolam | SOLUTION;INTRAVENOUS | 211844 | NDA | WG Critical Care, LLC. | 44567-610 | 44567-610-10 | 10 BAG in 1 CARTON (44567-610-10) / 50 mL in 1 BAG (44567-610-01) |
| MIDAZOLAM IN 0.9% SODIUM CHLORIDE | midazolam | SOLUTION;INTRAVENOUS | 211844 | NDA | WG Critical Care, LLC. | 44567-611 | 44567-611-10 | 10 BAG in 1 CARTON (44567-611-10) / 100 mL in 1 BAG (44567-611-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/50ML (1MG/ML) | ||||
| Approval Date: | Mar 22, 2021 | TE: | AP | RLD: | Yes | ||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Jun 20, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/100ML (1MG/ML) | ||||
| Approval Date: | Mar 22, 2021 | TE: | AP | RLD: | Yes | ||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Jun 20, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
